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Phagocytosis has long been recognized as one of the differentiated functions of the 
macrophage and yet many of the cellular and biochemical mechanisms underlying this 
process remain unclear. Rabinovitch has separated the process of phagocytosis into two 
phases:  attachment  and  ingestion  (1).  The  former is  dependent  both  on the  surface 
properties of the  cell  and  on the  particle  and is independent  of energy and  divalent 
cations, while the ingestion phase requires energy and divalent cations. Attachment can 
be mediated through binding to receptors on the macrophage surface for the C3 compo- 
nent of complement and the Fc portion of immunoglobulins. In studies on Fc-mediated 
and C3-mediated phagocytosis, Griffin et al. (2) observed that a particle will be ingested 
only if the macrophage receptors for that particle are able to bind the entire surface of the 
particle.  Thus,  the  initial  necessary attachment at  a  single  site is not sufficient for 
phagocytosis, but binding must occur on other sites of the particle during ingestion. In 
addition, these investigators found that erythrocytes attached to the macrophage surface 
with  cross-linking  antibody  would  not  be  ingested  during  the  phagocytosis  of other 
particles (3). Thus, phagocytosis was shown to occur not through a general activation of 
the membrane but rather through a localized or segmental response. In further studies, 
Griffin et al. demonstrated that particles bound to the macrophages by the C3 receptors 
were not phagocytized coincidentally during phagocytosis mediated through the Fc recep- 
tor (4). These studies have greatly extended our understanding of Fc-mediated phagocy- 
tosis by describing the selective interactions between particles and the phagocytic cell 
and additionally by distinguishing  various types of phagocytosis: nonspecific phagocy- 
tosis, Fc-mediated phagocytosis, and C3-mediated phagocytosis, the latter being carried 
out exclusively by activated macrophages (5). 
We  have  studied  the  mechanism  of  phagocytosis  in  a  cloned  continuous 
macrophage-like  cell  line  by  isolating  variant  clones  which  differ  from  the 
parental  cell  in phagocytosis of opsonized sheep red blood cells  (SRBC)2  The 
genetic  approach  has  two  advantages.  First,  the  use  of  a  cloned  cell  line 
eliminates  the  variation  in  properties  among  the  different  cell  types  in  a 
heterogeneous population  such  as primary macrophages.  Second,  because the 
isolation  of mutants  is  possible,  one  can  dissect  complex  mechanisms  into 
individual  steps. 
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A  reticulum cell sarcoma, J774  described by Ralph et al.  (6,  7),  displays a 
number of characteristics of primary macrophages, such as lysozyme synthesis 
and secretion, phagocytosis of carbon particles, expression of Fc receptors, and 
ingestion of erythrocytes coated with IgG. Using the continuous cloned cell line 
derived from this tumor, we have developed a "Trojan horse" selection scheme 
utilizing a toxic drug contained within the ingested particles. The rationale was 
that phagocytosis of opsonized erythrocytes  containing a lethal substance should 
result in the death of all phagocytic cells leaving as survivors a  population of 
variant cells either defective in  expression of the receptor, in the process of 
phagocytosis,  in  the  ability  to  degrade  erythrocytes when  phagocytized,  or 
resistant to the toxin. The toxic agent chosen for these studies was tubercidin, 
an adenosine analog, which is known to be sequestered by red blood cells and is 
found phosphorylated in  the red cell  (8).  By analogy with the four common 
ribonucleotides which are not transported in their phosphorylated forms (9), we 
reasoned that if during the selection the phosphorylated tubercidin should leak 
out of the red blood cells, it would probably not re-enter other cells and could 
simply be washed away. Using this selection scheme we have isolated a number 
of variants in phagocytosis and, in some instances, we have been able pharmaco- 
logically to correct the defect. 
Materials and Methods 
Cells.  J774.2, the cell line used in these experiments, is a cloned cell line which was adapted to 
in vitro culture from the tumor J774 (6) and selected for high levels of lysozyme secretion by L. 
Frank and M. Scharff,  and generously provided by  them. It  was recloned I  mo before  the  selection 
experiments to be described. J774.2 and its derivatives were grown beth in suspension  and in 
monolayer in Dulbecco's Modified Eagle's medium (DME) (Grand Island Biological  Co. [Gibco], 
Grand Island,  N. Y.)  supplemented with penicillin,  streptomycin, glutamine, nonessential amino 
acids, and 20% heat-inactivated horse serum (Gibco).  The cells  were kept in a humid incubator 
with an air mixture containing 5% CO2 at 37°C. Cells in suspension were counted directly  in a 
hemocytometer. Cells  in monolayer were trypsinized  in a known volume and then counted. 
Cloning.  All cloning was done in soft  agar in 25-cm  2  tissue  culture dishes  (Falcon Plastics, 
Oxnard, Calif.  no. 3007)  by the method of  Coffino  et  al. (10).  A monolayer of  the  rat  fibroblast  cell 
line 1706 (a gift  from M. Scharff)  was used as a feeder layer.  A solution  of  0.32% wt/vol agarose 
(Seakem, Marine Colloids,  Inc.,  Rockland, Me.) in medium was maintained at 42°C. 5 ml of  this 
solution  were layered onto the feeder  layer.  Then the  dishes were placed on a level  surface  at  4°C 
for 5 rain.  After the agarose had solidified,  the cells  to be cloned were applied to the top of  the 
dishes in a 0.29% wt/vol solution of  agarose in medium. The dishes were again cooled at 4°C to 
solidify  the agarose and then  placed  in  a moist  incubator at  37°C.  200 cells  per dish  were plated  and 
the cloning efficiencies  observed were between 40% and 80%. 
Preparation of  SRBC  Coated with  IgG (E[IgG]). The method used was that described by 
Bianco et al. (5).  SRBC  in Alsever's solution (obtained weekly from the Animal Blood Centre, 
Syracuse, N. Y.) were washed three times in Hanks solution,  resuspended to 5% (vol/vol),  and 
incubated with an equal volume of  Hanks containing anti-SRBC IgG (Lot  $0245, Cordis Laborato- 
ries,  Miami, Fla.)  so  that the  final  dilution  of  antiserum was 1:1,000.  This  antiserum agglutinated 
a 1% suspension of  SRBC at  a  titer  of  1:400.  The red  cell  antibody mixture was incubated for  30  min 
at 37°C, washed three times, and resuspended to 0.5% (vol/vol)  in DME  for use. 
Fc Rosettes  and Fc-Mediated Phagocytosis. Cover slips  were flamed in alcohol  and placed in 
25-cm  2 petri dishes to which approximately 5 x  105 cells  were added in 5 ml of medium  and 
incubated overnight. For the assay,  the cover slips  were removed and covered with the suspension 
of  E[IgG] and incubated for 1 h at 37°C. At that time, the cover slips  were rinsed in Hanks and 
examined for the number of cells  forming rosettes.  At least  100 cells  were counted. A  cell  was 
considered positive  if  three or more erythrocytes were bound to it. Then adsorbed red blood cells RUTH  J.  MUSCHEL,  NEAL  ROSEN,  AND  BARRY  R.  BLOOM  177 
were lysed by a  10-s dip in Hanks diluted  1:5 with distilled water,  and rinsed in full strength 
Hanks. The cells were then evaluated according to the number of erythrocytes ingested by each 
cell. Again, at least 100 cells were counted. Controls of red blood cells incubated without IgG were 
always included and never more than 4% of the cells ingested or bound any SRBC. 
Latex Particles Phagocytosis.  Cells were prepared as for the Fc-mediated phagocytosis assay. 
Latex particles,  1.1 ~m (Dow Diagnostics, Indianapolis, Ind.), were dialyzed extensively against 
distilled water before use.  For the assay,  latex particles suspended to 45  x  106 particles/ml in 
Hanks  were  applied  to  the  cover  slips.  After  1  h  at  37°C  the  cover  slips  were  rinsed  and 
phagocytosis was evaluated. Cells containing three or more particles were considered positive. At 
least 100 cells were counted for each determination. 
8 Br-cAMP Incubation.  Cover slips and cells were incubated overnight in medium containing 
0.5 mM 8-bromoadenosine 3':5' cyclic monophosphoric acid  (8 Br-cAMP) (Plenum Laboratories, 
Hackensack,  N.  J.) and 0.05 mM MIBX, a  phosphodiesterase inhibitor (Aldrich Chemical Co., 
Inc.,  Milwaukee,  Wis.).  The suspension of SRBC  coated with IgG used to test these cells also 
included these concentrations of the drugs. 
Selection Procedure.  The cells to be treated were plated in 5 ml at 5  x  105 cells per 25-cm  2 
tissue  culture  dish  and  cultured  overnight.  For  the  selection  procedure  some  aspects  of the 
preparation of SRBC coated with IgG (E[IgG]) were altered. In particular, during the incubation 
of SRBC  with  antiserum,  tubercidin  (a  generous  gift  of Dr.  G.  Whitfield,  The  Upjohn  Co., 
Kalamazoo, Mich.) was included at a final concentration of 500 ~g/ml and the incubation time was 
lengthened to  1 h.  Then the  E[IgG]  containing tubercidin were  washed five times  in  Hanks. 
E[IgG]  containing tubercidin  (2  ml  of a  0.5%  suspension)  were  added  to  the  dishes  after the 
medium had been aspirated. After 2 h  of incubation at 37°C,  the free E[IgG] were aspirated, the 
dishes were washed once with Hanks, the adsorbed erythrocytes were hypotenically lysed for 20 s 
as above, and the dishes were washed four times with Hanks solution, after which medium was 
added.  4 h  after the end of the first selection, 2 ml of the complexes containing tubercidin were 
again added to each dish and the procedure repeated.  The dishes were washed 2 days after the 
selection. 
Mutagenesis.  N-methyl-N'-nitro N-Nitrosoguanidine (NG) (Aldrich) was dissolved in ethanol 
and diluted in 0.01 M sodium acetate, pH 5, at a concentration of 30 ~g/ml. Cells were suspended 
in Hanks at a density of 1 x  108 cells/ml with 0.3 ~g NG/ml for 30 min. The cells were then washed 
and suspended in medium. After 2 days of incubation approximately 50% of the cells treated with 
NG survived as compared to control cultures without NG. 
Results 
Toxicity  of SRBC  Coated  with IgG Containing Tubercidin.  The  selection 
scheme  depended  on  the  ability  of J774.2  to  phagocytize  E[IgG]  containing 
tubercidin, and of the ingested tubercidin to result in the death of these cells. As 
shown  in  Table  I,  a  2-h  exposure  of J774.2  to  E[IgG]  containing  tubercidin, 
followed by lysis of the red blood cells  and extensive washing,  resulted in the 
death of 95% of the cells  at 3 days.  Since this amount of killing would not be 
sufficient to select for a variant present at low frequencies, we tried to maximize 
killing by a second cycle of the selective procedure 4 h  after the first selection. 
This resulted  in less than  0.1%  survival observed on day 3,  To show that the 
killing  was specific  for Fc receptor-mediated  phagocytosis the anti-SRBC  IgG 
was omitted from the selection  mixture.  By such a  procedure no Fc-mediated 
phagocytosis should occur and the extent of nonspecific killing could be assessed. 
In the experiment illustrated in Table I, only 25% of the cells were nonspecifi- 
cally killed, and in subsequent experiments this figure was reduced to 5-10% by 
washing the  cells  more thoroughly.  Thus,  the tubercidin  was  not killing  the 
cells after being released from nonphagocytized red blood cells or by adhering to 
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TABU  I 
Effect of SRBC Containing  Tubercidin 
Number of 
applications  IgG*  Number of cells$ x 105  Control (%) 
day I  day 3  day I  day 3 
0  -  2.7  6.0  100  100 
1  +  0.66  0.03  25  5 
2  +  0.06  <0.01  2  0 
2  -  2.3  4.5  82  75 
* Some  SRBC  containing tubercidin  were  prepared  in  the  absence  of anti- 
SRBC IgG.  +  or  -  indicates the presence or absence of the antiserum. 
$1 day and 3 days after treatment duplicate plates were counted, 
Application  of the Selection  Scheme.  J774.2  cells  were  mutagenized  with 
nitrosoguanidine  (NG), then plated at 5 ×  105 cells per dish and subjected to two 
cycles of the selection procedure. After 9 days, 37 discrete adherent clones with 
from 8 to 16 cells each were noted. We tested these clones directly on the dish for 
Fc receptors and Fc-mediated phagocytosis by removing the medium and incu- 
bating with 2 ml of E[IgG] for 1 h. 36 clones dearly made rosettes and so had Fc 
receptors.  One clone appeared negative.  The SRBC were lysed and the clones 
examined for phagocytosis. Of these clones, 25 had phagocytized almost no red 
blood cells,  6  contained  cells  which  had  ingested  many  red  blood cells  and 
therefore resembled the parental type, and 6 clones appeared to be made up of 
both phagocytic and nonphagocytic cells. The loose adherence of these clones to 
tissue culture dishes prevented the recovery of these clones by cloning cylinder 
methods. 
Isolation of Cloned Variant Populations.  To recover the potential  mutants 
as  clonal  populations,  cells  were  again  exposed to  NG  and  plated,  and  the 
selection procedure was performed in two cycles on these dishes. Four independ- 
ent selections were carried out.  After 2 wk of growth,  the selection procedure 
was repeated on each dish. 2 wk later, when each dish contained about 3  x  10  ~ 
cells,  the populations  were examined  for Fc-mediated phagocytosis and  each 
selection was found to have resulted in cells which were minimally phagocytic 
as compared to the parental cells. While 19% of J774.2 phagocytized no E[IgG], 
80-93% of the selected cells failed to phagocytize. Accordingly, cells from each of 
the four selections were cloned in soft agar and several clones from each were 
picked, grown, and independently maintained. 
We tested 40  clones drawn  from each  of the four selections.  All  clones ap- 
peared to have  Fc receptors.  (Greater  than  90%  of the  cells  in  each  formed 
rosettes.) 31 clones, however, were found to have a  reduced ability to phagocy- 
tize E [IgG]. 9 of the 40 were wild-type in regard to phagocytosis. The phagocytic 
patterns of sample clones are shown in Fig. 1. These examples demonstrate the 
variation in the extent of phagocytosis between the individual clones, although 
all are clearly deficient in phagocytosis when compared to the parental cell line. 
These  differences  are  a  stable  and  reproducible  property  of the  clones.  For 
example, cells of clone 12 from selection no. 4 (designated clone 4.12) contained 
95% nonphagocytic cells, clone 4.5, about 80% nonphagocytic cells, and clone 1.6 RUTH  J.  MUSCHEL,  NEAL  ROSEN~  AND  BARRY  R.  BLOOM 
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Fro.  1.  Fc-mediated phagocytosis by  J774.2  and variants in phagocytosis. The parent 
clones are shown with open bars and the subclones of  the parent clones with hatched bars. 
averaged about 50% nonphagocytic cells. No clone has yet been found in which 
there is a total absence of phagocytic cells. 
Recloning of Variant Clones.  We considered the possibility that the remain- 
ing low level of phagocytosis in the mutants might be due to mixed clones rather 
than representative of a true clonal phenotype, although this was unlikely since 
only 200 cells were cloned per dish.  To eliminate this possibility, we randomly 
chose 10 of the original parent clones to be recloned and tested. We found that 
subclones did not differ from their parent clone in the pattern of phagocytosis to 
any  noticeable  degree  (Fig.  1).  This  experiment  demonstrates  the  heritable 
nature of the nonphagocytic trait. 
When these recloned populations were additionally tested for phagocytosis of 
latex particles,  92-100%  of the cells in  each clone showed latex  phagocytosis 
(Table II). These levels are comparable to the level of 95% shown by J774.2. 
Effect of Tubercidin on the Variants.  The selection procedure described in 
this paper resulted in the isolation of clones showing reduced levels of phagocy- 
tosis.  The  possibility  was  considered  that  the  selection  might  have  allowed 
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TABLE II 
Phagocytosis  of Latex and E[IgG]  by 10 Variant Clones 
Cells phagocy-  Cells phagocy-  Clone tested  tizing latex  tizing >3 E[IgG] 
%  % 
J774.2 (parent)  95  75 
1.6  94  23 
1.11  100  20 
2.2  92  11 
3.3  100  6 
3.4  96  15 
3.11  100  15 
3.14  98  31 
3.15  95  23 
4.5  95  2 
4.12  97  0 
cells.  Since  mutants  in  the  degradative  processes  would  presumably  not  be 
altered  in  phagocytosis,  this  possibility  could  be  eliminated  at  least  for  the 
nonphagocytic variants. However, to confirm that the selection of cells resistant 
to  tubercidin  did  not  account  for our  results,  we  tested  the  susceptibility  of 
J774.2 to tubercidin as well as that of the 10 lines which had been recloned. All 
were exposed to tubercidin in the medium at 1 ~g/ml. We found that 4 days after 
placing approximately 2  ×  105 cells/ml in suspension culture in this concentra- 
tion of tubercidin there were no detectable survivors, while there were approxi- 
mately 6 ×  105 cells/ml in all control dishes without drug. Note that 0.1 ~g/ml is 
not toxic to these cells. Thus, the selection procedure employed appears to yield 
cells defective in phagocytosis and not resistant to tubercidin. 
Analysis of Wild-Type Clones.  The clones with wild-type phenotypes with 
respect to phagocytosis might be candidates for cells resistant to tubercidin or 
deficient in red blood cell degradation.  These two possibilities could be tested 
simultaneously by repeating  the selection procedure on these cells.  This was 
done on the nine clones which were wild-type in regard to phagocytosis, on clone 
4.5,  a  nonphagocytic  variant,  and  on  J744.2  itself  (Table  III).  Eight  of the 
phagocytic  clones  were  completely  killed  by the  selection  procedure  as  was 
J774.2.  Clone 4.5,  the nonphagocytic variant,  survived,  while the  phagocytic 
line 1.15 was not completely killed.  We have not further analyzed this partial 
resistance of clone 1.15. 
Effect of 8 Br-cAMP on Variants.  In other experiments we have found that 8 
Br-cAMP at 0.5 mM concentrations is capable of enhancing Fc-mediated phago- 
cytosis by J774.2  under  appropriate  conditions. 2 Consequently,  we tested the 
effect  of 8  Br-cAMP  on  the  variant  clones.  Some  clones  showed  a  marked 
increase in phagocytosis on addition of 8 Br-cAMP while others were unaffected 
in regard to phagocytosis. The phagocytic pattern of some clones in response to 8 
Br-cAMP is shown in Fig. 2. It can readily be seen that clone 1.6, which showed 
intermediate  levels  of phagocytosis,  maintained  the  same  pattern  after  the 
2 R. J. Muschel, O. M. Rosen, N. Rosen, and B. R. Bloom. Manuscript in preparation. RUTH  J.  MUSCHEL,  NEAL  ROSEN,  AND  BARRY  R.  BLOOM 
TABLE HI 
Effect of the Selection  Procedure on Phagocytic  Clones 
Cell tested  Survival at 3 days* 
% 
J774.2  0 
Phagocytic clones 
1.10  0 
1.15  I0 
2.1  0 
3.1  0 
3.2  0 
3.7  0 
3.12  0 
4.3  0 
4.8  0 
4.16  0 
181 
Nonphagocytic clone 
4.5  80 
* Percent survival was calculated by comparison with the number of 
cells on a dish treated with SRBC containing tubercidin but not coated 
with IgG. 
incubation with 8 Br-cAMP. Conversely, clone 1.11, which had a similar pattern 
under the original  conditions,  was highly phagocytic after treatment with the 
drug.  Clone  3.13,  which  was  only  negligibly  phagocytic  under  the  original 
conditions, was unaltered in phagocytosis by 8 Br-cAMP, whereas others such as 
4.12 or2.2 which were both nonphagocytic were markedly enhanced in phagocy- 
tosis of E[IgG] although to different extents; clone 4.12 had only 30% of its cells 
ingesting four or more red blood cells in 8 Br-cAMP, while clone 2.2 acquired 
phagocytic activity comparable  to the  parental  type.  Of 19 of the  original  31 
clones defective in phagocytosis, 11 showed some substantial degree of restora- 
tion  of Fc-mediated  phagocytosis  upon  treatment  with  8  Br-cAMP,  while  8 
showed no enhancement.  0.5 mM AMP was also tested and did not enhance Fc- 
mediated phagocytosis on two of the variants which were enhanced by 0.5 mM 8 
Br-cAMP. All 19 variants and J774.2 showed at least 90% of their cells forming 
Fc rosettes in 8 Br-cAMP. In addition, we tested the 10 recloned lines in this way 
and  compared  their  behavior  to  the  10  parental  lines  and  again  found  no 
differences between the parent clone and the subclone. 
Discussion 
In the present  experiments  we have isolated variants  in  the  mechanism  of 
phagocytosis  by  means  of somatic  cell  genetical  techniques  using  a  cloned 
continuous macrophage-like  cell  line,  J774.2.  These variants  were stable and 
showed  different  phagocytic  patterns,  with  some being  correctable  by 8  Br- 
cAMP.  They  were  isolated  by  a  strategy  using  IgG-coated  SRBC  (E[IgG]) 
containing  the  toxic  drug  tubercidin.  A  similar  approach  has  recently been 
reported by Refsnes and Munthe-Kaas (11) who used immune complexes of ricin 
to kill primary macrophages.  We have demonstrated that J774.2 is susceptible 182  ISOLATION  OF  VARIANTS  IN  PHAGOCYTOSIS 
CLONE 16  CLONE  ],1] 
1@@[ 
L 
60 
ao 
4O 
2 
BB~  .... 
0  I  2 ~ ~4  0  I  2  :.4 
CLONE 2.2  CLONE  3J5  CLONE  412  J i'74 2 
.°.° 
0  1  2  3";4  123;4 
NUMBER  SRBC  INGESTED 
BBB  BB.= 
I  2  3~'4  0  1 2  3s4 
~oo  CLONE  ].6  CLONE  I.I]  CLONE  2.2  CLONE  ,~.13  CLONE  4.12  J774.2 
BO 
6O 
co 
I 
40 
%J 
 l,,a  i,°l  .._°  .°°o  ,o,, 
0  I  2  5 ;4  I  2  $s4  I  2 5 ;4  I  2 5';4  I  2  ~;4  0  I  2  `];4 
NUMBER SRB,  INGESTED 
Patterns  of Fc-mediated  phagocytosis  by J774.2  and some variant  clones p|us and  FIG.  2. 
minus 8 Br-cAMP. Cells grown in the absence of 8 Br-cAMP are shown in the lower panel; 
cells grown in the presence of  0.5 mM 8 Br-cAMP and 0.05 mM MIBX are shown in the upper 
panel. 
to lethal effects of tubercidin contained in E[IgG] and that the killing was due 
specifically to Fc-mediated phagocytosis since the presence of sheep erythrocytes 
containing tubercidin in the absence of IgG had only a slightly toxic effect (Table 
I).  This  method has permitted  us to isolate variants  which are in  some way 
defective in the process of phagocytosis. It is to be noted that in order to isolate 
variants which occur at low frequencies, it has been empirically found that two 
cycles of treatment are more effective. The requirement for two selection cycles 
may be related to the cell cycle or may be due to random variation in phagocyto- 
sis among cells in the population. 
Variants which survived the selection procedure were cloned and compared to 
the parental cell in regard to various processes in which predicted defects might 
have allowed survival.  In particular,  the following were considered: (a) resist- 
ance  to  the  drug  tubercidin;  (b)  defects  in  the  intracellular  degradation  of 
erythrocytes; (c) complete loss of Fc receptors; (d) defects in phagocytosis per se. 
We found only one clone which might fit into categories (a) or (b), clone 1.15, RUTH  J.  MUSCHEL~  NEAL  ROSEN 9  AND  BARRY  R.  BLOOM  183 
which  was phagocytic but weakly survived the  reapplication  of the  selection 
scheme. All other phagocytic clones appeared to be wild-type in these respects. 
Cells defective in Fc-mediated phagocytosis were also anticipated and found 
in relative abundance.  Variants with defects in Fc-mediated phagocytosis were 
detected at a frequency of 31 per 5 × 10  ~ or 6 x  10  -5 after NG treatment. This is a 
frequency consistent with mutation,  especially if the assumption is made that 
several genes are involved in the process. The property of defective phagocytosis 
has been shown to be stable and heritable by recloning. By a simple definition of 
mutation as a heritable change in phenotype, these clones could be judged to be 
mutants. We prefer, however, to use the term variant rather than mutant when 
referring to these cells, until a  mutant gene product can be demonstrated. 
Fc-mediated phagocytosis has been experimentally separated into two phases: 
attachment  via the Fc receptor,  and ingestion  (1).  One could predict that the 
variants might prove to be defective in one or other phase.  All of the isolated 
clones exhibited Fc receptors, although one clone was found which appeared to 
lack  the  Fc receptor  but  it  could not  be recovered.  However,  the  results  of 
Unkeless and  Eisen  (12)  and  of Walker  (13)  suggest that  there  are  different 
receptors for the Fc portions of IgG 2a and IgG 2b. Therefore, a positive result in 
the rosetting assay used in these experiments does not definitely exclude the loss 
of one type of Fc receptor if J774.2 had both types. If any of the variants had lost 
one receptor but not both, it would represent a  cell which might still form Fc 
rosettes but in which phagocytosis might be impaired due to the lack of a  Fc 
receptor for a different class of immunoglobulin.  We cannot at present conclude 
that the variants have a  full complement of Fc receptors.  Experiments  are in 
progress to examine the Fc receptors for the IgG subclasses in the variants. 
This  work  also  extends  the  observations  of Griffin  and  Silverstein  (3)  in 
regard  to  the  relationship  of attachment  to  ingestion.  They have  elegantly 
shown the necessity of binding via the Fc receptor for phagocytosis of red blood 
cells by normal macrophages. Other sorts of artificial attachments did not result 
in phagocytosis.  Our results  supplemented these observations by showing at- 
tachment to an Fc receptor is not itself a  sufficient condition for phagocytosis. 
This result may be interesting in regard to possible distinctions between Fc re- 
ceptors and their functions in binding,  in phagocytosis and in cytolysis. 
While most studies of phagocytosis have assumed that the process was inde- 
pendent of the nature of the particle studied, the mechanisms of latex phagocy- 
tosis and Fc receptor-mediated phagocytosis have recently been experimentally 
differentiated by Michl et al.  (14) using the drug 2-deoxy-glucose, which mark- 
edly inhibited Fc-mediated phagocytosis without altering Fc rosetting or inges- 
tion of latex particles.  This has been confirmed in the present experiments,  in 
which  we took variant  clones defective in phagocytosis of E[IgG] and  tested 
them for the ability to phagocytize latex particles. All were positive. From these 
data, it seems clear that latex- and Fc-mediated phagocytosis occur by different 
mechanisms,  since pharmacologic agents can block the latter process, leaving 
the  former  intact,  and  since  variants  in  Fc-mediated  phagocytosis  are  not 
altered in their ability to phagocytize latex particles. 
Finally,  we found that Fc-mediated phagocytosis by some but not all of the 
variants would be enhanced by 8 Br-cAMP (Fig. 2).  We have noted essentially 184  ISOLATION  OF  VARIANTS  IN  PHAGOCYTOSIS 
five classes of variants in regard to Fc-mediated phagocytosis in the presence 
and absence of 8 Br-cAMP. Fig. 2 shows one example of each type: a  variant 
which has intermediate levels of Fc-mediated phagocytosis and another which 
has almost no Fc-mediated phagocytic ability are both not altered in phagocyto- 
sis by 8 Br-cAMP.  On the other hand, one intermediate type (1.11),  and (2.2) 
almost completely  lacking in phagocytosis were both fully converted to wild-type 
levels of Fc-mediated phagocytosis by 8 Br-cAMP, while the fifth class was 
boosted to an intermediate level only. In addition to suggesting the involvement 
of the cAMP system in phagocytosis, these results make it necessary to consider 
that some of the variants may have defects in cAMP metabolism. 
A large amount of literature exists on changes in intracellular levels of cyclic 
nucleotides in  neutrophils  and  macrophages after phagocytosis  (15-18), but 
there has been up to now no formal evidence that cAMP is required in the 
phagocytic process.  At least two reports in the literature have concluded that 
cAMP inhibits Fc rosetting and phagecytosis. Zuckerman and Douglas (19) re- 
ported that cholera toxin, a drug known to activate adenylate cyclase, reduced 
the number of Fc rosetting cells in a lymphoblastoid cell line. However, the con- 
centration of cholera toxin required for this effect was 1,000 times greater than 
that needed optimally to elevate cAMP in their hands, and it may be questioned 
whether the effect was primarily related to the action of cholera toxin in raising 
cAMP levels or to some secondary effect. Secondly, Cruchard et al.  (20) have 
reported an inhibitory action of dibutyryl cAMP on Fc-mediated phagecytosis 
at a  minimum concentration of 10  -~ M.  Since the enhancement we have ob- 
served occurs at a concentration of 5  ×  10  -4 M, it is difficult directly to compare 
these observations. 
Since we have isolated some variants that were enhanced in phagocytosis by 8 
Br-cAMP and some that were not, it might not be unreasonable to consider two 
components of Fc-mediated phagocytosis, one dependent on cAMP, the other 
independent. If we accept the hypothesis of Kuo and Greengard (21), that in 
eukaryotes cAMP acts exclusively through its interaction with cAMP binding 
protein phosphokinases, it becomes apparent that mutations within the cAMP 
system itself could produce both effects. If cAMP truly enhances Fc-mediated 
phagocytosis physiologically, mutations either in adenylate cyclase or in the 
appropriate cAMP binding protein phosphokinase might lead to the phenotypes 
which we have observed; adenylate cyclase mutants being enhanced by 8 Br- 
cAMP and cAMP binding protein phosphokinase mutants perhaps being unin- 
fluenced by the drug. Viable mutants in cAMP metabolism have been isolated in 
other cell lines,  e.g.,  mutants in adenylate cyclase (22) and cAMP binding 
phosphokinase (23, 24). On the other hand, both classes of variants described 
here could result from mutation outside the cAMP system itself. These possi- 
bilities are susceptible to experimental analysis. 
Summary 
We have isolated cloned variants in phagocytosis from a cloned continuous 
murine macrophage-like cell  line,  J774.2.  A  selection procedure against  Fc 
receptor-mediated  phagocytosis was devised using IgG-coated SRBC containing 
a toxic drug, tuberc,.'din, as the lethal agent. A series of variant clones deficient 
in Fc receptor-mediated phagocytosis were isolated. Such variants occurred at RUTH J.  MUSCHEL, NEAL ROSEN~ AND  BARRY R.  BLOOM  185 
low frequency (-6  ×  10-~), were stable, and appeared to possess Fc receptors. 
The degree to which they were defective in phagocytosis of IgG-coated SRBC 
varied from clone to clone, yet all clones were able to phagocytize latex parti- 
cles. The phagocytic defect in some variants could be corrected by the addition of 
8 Br-cAMP, in others, the drug was without effect. It is likely, therefore, that 
different variants are defective in several distinct steps critical to Fc receptor- 
mediated phagocytosis. 
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